Finasteride Market Analysis

  • Report ID: 2984
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Finasteride Market Analysis

The market is segmented by application into prostate treatment, hair treatment and others, out of which, the segment for prostate treatment is anticipated to hold the largest share in the finasteride market on account of the rising cases of benign prostate hyperplasia (BPH). As per the Urology Care Foundation, about half of the men between the ages 51 and 60 years suffer from BPH. 90% of the men above the age of 80 years already have this disorder. High occurrence of the risk factors such as age, improper nutrition and genetic susceptibility are considered to be the underlying causes of the rapid spread of this condition since the last decade. The hair treatment segment is also predicted to observe notable growth over the forecast period owing to the growing incidence of alopecia among young adults and rise in emphasis on physical appearance. Additionally, on the basis of distribution channel, the online pharmacy segment in the market is assessed to witness the highest growth by the end of 2030. This can be credited to the consumer shift toward smart phones and digital technology, and increasing number of online medical stores over the last few years.

Our in-depth analysis of the global market includes the following segments:

           Product Type

  • 1 mg
  • 5 mg

             Application

  • Prostate Treatment
    • Prostate Cancer
    • Prostate Enlargement
    • Hormone Therapy
  • Hair Treatment
    • Scalp Hair Loss
    • Excessive Hair Growth
  • Others

           Distribution Channel

  • Online Pharmacy
  • Offline Pharmacy
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2984
  • Published Date: Sep 03, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of finasteride is estimated at USD 111.87 million.

Finasteride Market size was over USD 109.5 million in 2023 and is anticipated to reach USD 154.82 million by 2036, growing at around 2.7% CAGR during the forecast period i.e., between 2024-2036. The market growth is impelled by increasing occurrence of hair loss and prostate cancer and growing R&D activities in the pharmaceutical sector.

Asia Pacific is set to hold largest revenue share by 2036, on the back of growing penetration of finasteride in developing and under-developing countries.

The major players in the market are Novartis International AG, Merck Sharp & Dohme Corp., Teva Pharmaceuticals Limited, RelconChem Limited, Cipla Ltd., and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample